نتائج البحث - Cynthia Serdikoff

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1
    Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

    Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders حسب Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan, Cezary Swider, Candy Robinson, Yang Shi, Thelma S. Angeles, Stephen G. Emerson, Martin Carroll, Bruce Ruggeri, Paweł Dobrzański

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

    A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis حسب Kristine L. Stump, Lily Lu, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

    Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2 حسب Lily Lu, Kristine L. Stump, Nate H. Wallace, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Jennifer Mason, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: